HCONRES 42 · 117th Congress 2021–2023, ended

Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Latest action · Jul 22, 2021 Referred to the Subcommittee on Health.

Progress

Where this resolution reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried. A concurrent resolution must be agreed to by both chambers, but it is not presented to the President and does not become law.

  1. IntroducedJul 21, 2021
  2. Agreed to in HouseNot reached
  3. Agreed to in SenateNot reached

Summary

This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.

Cosponsors 17

Members who signed on, in the order they did. Signatures ran from Jul 21, 2021 to Dec 9, 2021; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-MDDavid J. TroneOriginalJul 21, 2021
R-SCWilliam R. Timmons IVAug 3, 2021
D-PAMadeleine DeanAug 6, 2021
R-IAMariannette Miller-MeeksAug 6, 2021
R-ARJ. French HillSep 14, 2021
D-ILRaja KrishnamoorthiSep 14, 2021
D-OHTim RyanSep 22, 2021
R-ILRodney DavisSep 28, 2021
R-SCJoe WilsonOct 5, 2021
D-NHChris PappasOct 8, 2021
D-CAMark DeSaulnierOct 8, 2021
R-NYAndrew R. GarbarinoOct 19, 2021
D-MNAngie CraigOct 19, 2021
R-PABrian K. FitzpatrickOct 19, 2021
R-SCJeff DuncanOct 19, 2021
R-KYHarold RogersOct 26, 2021
R-SCNancy MaceDec 9, 2021

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jul 21, 2021
Health Subcommittee
Referred Jul 22, 2021

Actions 3

Everything that happened, newest first.

  1. Jul 22, 2021Referred to the Subcommittee on Health.
  2. Jul 21, 2021Introduced in House
  3. Jul 21, 2021Referred to the House Committee on Energy and Commerce.

Titles 1

Every title it has carried, official and short, at each stage.

Official Title as Introduced
Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jul 21, 2021Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this resolution on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.